Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.
Sugino F, Nakane K, Kawase M, Ueda S, Tomioka M, Takeuchi Y, Tomioka-Inagawa R, Yamada T, Namiki S, Kumada N, Takeuchi S, Kawase K, Kato D, Takai M, Iinuma K, Tobisawa Y, Koie T.
Sugino F, et al. Among authors: tobisawa y.
Life (Basel). 2023 Apr 23;13(5):1072. doi: 10.3390/life13051072.
Life (Basel). 2023.
PMID: 37240717
Free PMC article.